Literature DB >> 20950134

Exhaled nitric oxide in children with allergic rhinitis and/or asthma: a relationship with bronchial hyperreactivity.

Giorgio Ciprandi1, Maria Angela Tosca, Michele Capasso.   

Abstract

BACKGROUND: Nowadays, the measure of the fractional concentration of exhaled nitric oxide (FeNO) enables to assess airway inflammation during an office visit and there is international consensus on this testing methodology. The aim of this study was to evaluate whether FeNO measurement is predictable for bronchial hyperreactivity (BHR) in children with allergic rhinitis, asthma, or both.
METHODS: Two hundred and eighty children with allergic rhinitis, allergic asthma, or both were evaluated. Bronchial function (FEV₁ and FEF(25-75)), BHR (assessed by methacholine challenge), FeNO, and sensitizations were assessed.
RESULTS: Bronchial function, BHR, and FeNO were significantly different in the three groups (p < .001). A strong inverse correlation between FeNO and BHR was found in patients with asthma and with asthma and rhinitis (r = -0.63 and r = -0.61, respectively). A cutoff of 32 ppb of FeNO was a predictive factor for BHR.
CONCLUSIONS: This study highlights the relevance of FeNO as possible marker for BHR in allergic children and underlines the close link between upper and lower airways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20950134     DOI: 10.3109/02770903.2010.527026

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  14 in total

Review 1.  Treatment of Allergic Rhinitis as a Strategy for Preventing Asthma.

Authors:  Jaymin B Morjaria; Massimo Caruso; Rosalia Emma; Cristina Russo; Riccardo Polosa
Journal:  Curr Allergy Asthma Rep       Date:  2018-03-24       Impact factor: 4.806

2.  Comparison of orally exhaled nitric oxide in allergic versus nonallergic rhinitis.

Authors:  A Fusun Kalpaklioglu; Ilkay K Kalkan
Journal:  Am J Rhinol Allergy       Date:  2012 Mar-Apr       Impact factor: 2.467

Review 3.  Clinical application of exhaled nitric oxide measurement in pediatric lung diseases.

Authors:  Angelo Manna; Carlo Caffarelli; Margherita Varini; Carlotta Povesi Dascola; Silvia Montella; Marco Maglione; Francesco Sperlì; Francesca Santamaria
Journal:  Ital J Pediatr       Date:  2012-12-31       Impact factor: 2.638

4.  Obesity can influence children's and adolescents' airway hyperresponsiveness differently.

Authors:  Bruno Sposato; Marco Scalese; Maria Giovanna Migliorini; Maria Piera Riccardi; Massimo Tosti Balducci; Luigi Petruzzelli; Raffaele Scala
Journal:  Multidiscip Respir Med       Date:  2013-09-12

5.  Fractional exhaled nitric oxide and impulse oscillometry in children with allergic rhinitis.

Authors:  Yoon Hee Kim; Hyun Bin Park; Min Jung Kim; Hwan Soo Kim; Hee Seon Lee; Yoon Ki Han; Kyung Won Kim; Myung Hyun Sohn; Kyu-Earn Kim
Journal:  Allergy Asthma Immunol Res       Date:  2013-08-22       Impact factor: 5.764

6.  Small airway impairment and bronchial hyperresponsiveness in asthma onset.

Authors:  Bruno Sposato; Marco Scalese; Maria Giovanna Migliorini; Maurizio Di Tomassi; Raffaele Scala
Journal:  Allergy Asthma Immunol Res       Date:  2014-02-11       Impact factor: 5.764

7.  Correlation of exhaled nitric oxide, nasal nitric oxide and atopic status: A cross-sectional study in bronchial asthma and allergic rhinitis.

Authors:  Nitesh Gupta; Nitin Goel; Raj Kumar
Journal:  Lung India       Date:  2014-10

8.  BMI can influence adult males' and females' airway hyperresponsiveness differently.

Authors:  Bruno Sposato; Marco Scalese; Nicola Scichilone; Andrea Pammolli; Massimo Tosti Balducci; Maria Giovanna Migliorini; Raffaele Scala
Journal:  Multidiscip Respir Med       Date:  2012-11-17

9.  Nitric oxide in asthma physiopathology.

Authors:  Carla M Prado; Mílton A Martins; Iolanda F L C Tibério
Journal:  ISRN Allergy       Date:  2011-04-19

Review 10.  Exhaled NO: Determinants and Clinical Application in Children With Allergic Airway Disease.

Authors:  Hyo Bin Kim; Sandrah P Eckel; Jeong Hee Kim; Frank D Gilliland
Journal:  Allergy Asthma Immunol Res       Date:  2015-07-02       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.